Immunic (IMUX) Net Income - Minority (2013)
Immunic's (IMUX) quarterly Net Income - Minority came in at -$83.5 million in Q4 2013.
Immunic (IMUX) Net Income - Minority (2013) Analysis & Trends
Immunic has disclosed Net Income - Minority across 1 years of filings, most recently posting -$83.5 million for Q4 2013.
- Net Income - Minority for Q4 2013 came in at -$83.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2013 was -$83.5 million (changed N/A YoY), and the FY2013 annual result was -$83.5 million, changed N/A from the prior year.
- Net Income - Minority came in at -$83.5 million for Q4 2013 at Immunic.
- In the past five years, Net Income - Minority ranged from a high of -$83.5 million in Q4 2013 to a low of -$83.5 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Immunic | 384.84 Mn | 198.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -83.48 Mn |